Given multiple lines of evidence from humans and mice suggesting a key role for SH2B3 to limit BP elevations and end-organ damage in hypertension, SH2B3 represents a potential therapeutic target to modulate T-cell phenotype and hypertension severity. This evidence concerns the gene SH2B3 and Hypertension.